Seelos Therapeutics Files Paperwork for $14 Million Offering

On 1/22/20 Seelos Therapeutics filed the paperwork for a $14 million offering of its common stock. The NY, NY based clinical-stage company is focused on developing products to address unmet needs in the CNS arena. They trade on NASDAQ under the symbol "SEEL."